PharmaShots | Incisive News in 3 Shots

Subscribe Now

cancer

AbbVie to Acquire ImmunoGen for $10.1B

AbbVie to Acquire ImmunoGen for $10.1B

December 1, 2023

Biosimilar Solutions Reports the Initiation of Registrational Clinical Trials for Biosimilar BSC0826 to Treat Cancer

Biosimilar Solutions Reports the Initiation of Registrational Clinical Trials for Biosimilar BSC0826 to Treat Cancer

April 13, 2022

Regeneron Entered into a License Agreement with Nykode to Develop Vaccines Against Cancer and Infectious Diseases

Regeneron Entered into a License Agreement with Nykode to Develop Vaccines Against Cancer and Infectious Diseases

November 23, 2021

CStone Signs an Exclusive License Agreement with Jiangsu Hengrui to Develop and Commercialize CS1002 in Greater China

CStone Signs an Exclusive License Agreement with Jiangsu Hengrui to Develop and Commercialize CS1002 in Greater China

November 22, 2021

Innovent Entered into a Collaboration Agreement with NeoCura to Evaluate Sintilimab + NEO_PLIN2101 for Cancer in China

Innovent Entered into a Collaboration Agreement with NeoCura to Evaluate Sintilimab + NEO_PLIN2101 for Cancer in China

October 28, 2021

Genentech Signs a License Agreement with Adaptimmune to Develop and Commercialize Cancer-Targeted Allogeneic T-cell Therapies

Genentech Signs a License Agreement with Adaptimmune to Develop and Commercialize Cancer-Targeted Allogeneic T-cell Therapies

September 8, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us